Breaking News

Financial Report: Quintiles

February 12, 2016

Product Development revenues up 9% in the quarter

Quintiles

4Q Revenues: $1.5 billion (+8%)

4Q Earnings: $108.1 million (earnings were $88,444 4Q14)

FY Revenues: $5.7 billion (+5%)

FY Earnings: $388.3 million (+9%)

Comments: Product Development revenues were $845.7 million in the quarter, up 9% but negatively impacted by $22.4 million from unfavorable foreign exchange. The Integrated Healthcare Services revenues were $282.9 million, down 2%, negatively impacted by $13.1 million from unfavorable foreign exchange. New business of $1.49 billion was recorded in the quarter, representing a book-to-bill ratio of 1.32.
  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems